Stock_Titan Posted - 10 hours ago

$ALKS Alkermes to Report First Quarter Financial Results on May 1, 2024 https://www.stocktitan.net/news/ALKS/alkermes-to-report-first-quarter-financial-results-on-may-1-3sgs7b91zejg.html

Shanghi18 Posted - 12 hours ago

$ALKS out 24.46 w 1.5% . Crappy mkt day. I'll take it

Shanghi18 Posted - 14 hours ago

$ALKS in 24.08 with a wicked tight stop. Didn't even chk RSI but this is beat down

PrivateEquity101 Posted - 1 day ago

$ALKS 💸💸💸💸 keep on bringing it down!!

PrivateEquity101 Posted - 5 days ago

$ALKS the fact people are bullish on this tells me there are true morons out there who trade stocks 😂😂😂 you will make money in this being short all the way down to $15....

Broncos07 Posted - 5 days ago

$ALKS liking the looks of lvl 2 … maybe a halt on the way up? 😉 we can hope!

PrivateEquity101 Posted - 5 days ago

@Broncos07 was referring to $ALKS

Broncos07 Posted - 6 days ago

$MNDR on the dip situation- $ALKS just tanked…. Might b 1 to watch when it calms down…. IMO… not advice. Do you DD

TeresaTrades Posted - 6 days ago

Largest PUT OI decreases $ALKS $TSLA $CMCSA $NVAX $AGNC

WaynD01 Posted - 1 week ago

$ZVRA Yesterday, $200M was added to the $ALKS MC by a 9/8 patients Narco/IH phase 1b study result. How much value addition we got from a 48 person phase 2 result? https://investor.alkermes.com/news-releases/news-release-details/alkermes-announces-positive-topline-results-phase-1b-study-alks

AnaChart Posted - 1 week ago

$ALKS https://anachart.com/wp-content/uploads/ana_temp/1712689349_soc-img.jpg

OpinicusTrades Posted - 1 week ago

4 stocks to watch today: $TLRY $GE $TSM $ALKS

tradingtwenty Posted - 1 week ago

$ALKS has trended 2 times in the past 24 hours (based on 5 minute intervals). Latest press release on Apr 09, 2024 07:00 AM: Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness... Link: https://tradingtwenty.com/news/423030/alkermes-announces-positive-topline-results-from-phase-1b-study-of-alks-2680-demonstrating-improved-wakefulness-in-patients-with-narcolepsy-type-2-and-idiopathic-hypersomnia

OpenOutcrier Posted - 1 week ago

$ALKS (+6.9% pre) Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia - PRN https://ooc.bz/l/29845

DonCorleone77 Posted - 1 week ago

$ALKS Alkermes' ALKS 2680 improves wakefulness in Phase 1b narcolepsy study Alkermes announced positive topline results from the narcolepsy type 2 - NT2 - and idiopathic hypersomnia - IH - cohorts of a phase 1b, proof-of-concept study evaluating ALKS 2680, the company's novel, investigational, oral orexin 2 receptor agonist in development as a once-daily treatment for narcolepsy. ALKS 2680 data demonstrated clinically meaningful and statistically significant improvements from baseline in mean sleep latency on the Maintenance of Wakefulness Test vs. placebo at all doses tested. ALKS 2680 was generally well tolerated in both patient populations at all doses tested. The company plans to initiate a phase 2 study in patients with NT2 in the second half of 2024. Alkermes expects to submit results from this phase 1b, proof-of-concept study to a peer-reviewed journal for publication and to present additional ALKS 2680 study results at upcoming scientific meetings.

Stock_Titan Posted - 1 week ago

$ALKS Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia https://www.stocktitan.net/news/ALKS/alkermes-announces-positive-topline-results-from-phase-1b-study-of-vx911duv6ckp.html

PrivateEquity101 Posted - 1 week ago

$ALKS I'll buy this when it goes under $20 -- Until then, short the heck out of this. CEO is a clown, DEI initiatives up the wazoooo... some would wonder if they even care about the science anymore...

Stock_Titan Posted - 1 week ago

$ALKS Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society https://www.stocktitan.net/news/ALKS/alkermes-presents-analyses-from-long-term-safety-study-of-lybalvi-r-7ba4qyhouamr.html

PrivateEquity101 Posted - 2 weeks ago

$ALKS any one not shorting this is a clownn, just like their CEO. Layoffs every week. Positions overrun by DEI hires. CEO is running company into the ground.

StockInvest_us Posted - 2 weeks ago

Signal alert: $ALKS - PivotPoint bottom https://stockinvest.us/l/FQf9MfCf3I

Fullratio Posted - 03/27/24

Healthcare sector stocks with high YoY EPS growth in Q4 2023: $ROIV $ZBH $ALKS

StockInvest_us Posted - 03/22/24

Signal alert: $ALKS - PivotPoint bottom https://stockinvest.us/l/Rtf2vZAojG

PrivateEquity101 Posted - 03/20/24

$ALKS short this into the ground. bad product. even worse leadership.

richardred Posted - 03/19/24

$ALKS IMO one of the biggest values in Bio. Who knows maybe partner J&J might want the whole thing?

Quantumup Posted - 03/19/24

Baird🏁 $ALKS OP/$37 Notes rev guide $1.5B-$1.6B/>$800M in cash=solid fl; believes ALKS 2680 has💪🏽pot for narcolepsy type 1 (allots $7 per shr & *leaves narcolepsy type 2/idiopathic hypersomnia as*upside), as drug works on the causal pathway of disease, w/ compelling P1b data2date.

stoxx0007 Posted - 03/19/24

$ALKS = but more insiders selling is not looking good here. 😕

stoxx0007 Posted - 4 weeks ago

$ALKS = since there's a huge short position here.... I'd like to see a massive short squeeze to take ALKS above $60

StockInvest_us Posted - 1 month ago

Signal alert: $ALKS - Oversold Trend Short (Undervalued) https://stockinvest.us/l/pTM5IRwtND

Walls10 Posted - 1 month ago

@Thiel44 @Hawaiianinvesta he definitely knew what he was/is doing with $ALKS and $IRWD

BitJennie700k Posted - 1 month ago

$ALKS starter